Vanda Pharmaceuticals

Price & Volume

Stats

52W Range	$3.85-$6.75
Market Cap	$254.8M
Shares Short	4M

Financials

Revenue (12 Mos)	$198.7M
Revenue Growth (YoY)	17.5%
Gross Profit (12 Mos)	$187.4M
Diluted EPS	-$0.33

News

Yahoo Finance • 2 months ago

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

Yahoo Finance • last year

Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology Journal

Yahoo Finance • last year

Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results

Yahoo Finance • 2 years ago

Q1 2023 Vanda Pharmaceuticals Inc Earnings Call

About

CEO	Dr. Mihael H. Polymeropoulos M.D.
CFO	Mr. Kevin Patrick Moran
Address	2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	368